Tralokinumab - CAS 1044515-88-9

Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumab's potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermatitis (AD) .

Interleukin, Cadherin, Caspase, Apoptosis, IL Receptor

Cytoskeletal Signaling, Apoptosis, Immunology/Inflammation, Proteases/Proteasome

1044418

1

-20°C

Ice Packs

Inhibitory Antibodies